This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now
by Zacks Equity Research
FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.
FMSNegative Net Change WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change
medical medical-devices
CVS Health Drives Drug Affordability by Promoting Competition
by Moumi Mondal
CVS strengthens Caremark's PBM edge with formulary shifts, new partnerships and cost-saving wins for clients.
AMZNPositive Net Change UNHPositive Net Change CVSPositive Net Change
medical medical-devices
ISRG SP Platform's Expansion in Korea and Europe Gains Traction
by Indrajit Bandyopadhyay
Intuitive Surgical's SP platform gains momentum with 112% growth in Korea and steady European uptake, highlighting global adoption despite regional headwinds.
SYKPositive Net Change ISRGPositive Net Change ZBHNegative Net Change
medical medical-devices
Here's Why You Should Add Inogen Stock to Your Portfolio Now
by Zacks Equity Research
Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
WSTNegative Net Change AXGNNegative Net Change INGNNegative Net Change NVSTNegative Net Change
medical medical-devices
Should You Hold STERIS Stock in Your Portfolio Right Now?
by Zacks Equity Research
STE posts solid Healthcare and AST growth with strong liquidity but faces macroeconomic and currency headwinds.
CAHPositive Net Change MASINegative Net Change STEPositive Net Change PAHCPositive Net Change
medical medical-devices
Do Options Traders Know Something About Varex Imaging Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to VREX stock based on the movements in the options market lately.
VREXPositive Net Change
medical medical-devices
Hims & Hers Expands Care Ecosystem via Global and Digital Innovation
by Zacks Equity Research
HIMS is scaling globally with AI-powered care, new treatments and an $870 million boost to expand its digital ecosystem.
HIMSNegative Net Change DOCSNegative Net Change TEMNegative Net Change
medical medical-devices
Stryker Expands R&D Facility in India to Boost Medtech Innovation
by Zacks Equity Research
SYK expands its Bangalore R&D hub to accelerate robotics, AI and digital health innovation while deepening ties with India's talent pool.
SYKPositive Net Change WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change
medical medical-devices
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
by Zacks Equity Research
ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.
ANGOPositive Net Change WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change
medical medical-devices
Reasons to Retain Cooper Companies Stock in Your Portfolio for Now
by Zacks Equity Research
COO's premium lens strategy, MiSight myopia leadership, and fertility portfolio fuel long-term growth despite near-term headwinds.
COOPositive Net Change WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change
medical medical-devices
Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now?
by Zacks Equity Research
DGX posts strong gains from physician and hospital channels while advancing AI-powered solutions.
DGXPositive Net Change CAHPositive Net Change MASINegative Net Change PAHCPositive Net Change
medical medical-devices
HOLX vs. TMO: Which Diagnostic Giant Is the Stronger Buy Today?
by Moumi Mondal
Diagnostic leaders Hologic and Thermo Fisher post raised outlooks, acquisitions and strong product momentum.
TMOPositive Net Change HOLXNegative Net Change
medical medical-devices
Jefferies (JEF) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
JEFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Shattuck Labs, Inc. (STTK) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
STTKPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
The Zacks Analyst Blog Highlights AbbVie, ServiceNow, Boeing, Tucows and and Ampco-Pittsburgh
by Zacks Equity Research
Zacks spotlights AbbVie, ServiceNow, Boeing, Tucows, and Ampco-Pittsburgh, detailing growth drivers, headwinds, and industry positioning.
BANegative Net Change TCXPositive Net Change APNegative Net Change ABBVPositive Net Change NOWPositive Net Change
aerospace computers internet-content medical-devices pharmaceuticals
CVS Health Steps Up to Bolster Oak Street as Cost Pressures Mount
by Moumi Mondal
CVS trims its outlook as Oak Street faces rising medical costs, but new leadership and tech upgrades aim for steady growth.
CIPositive Net Change CVSPositive Net Change ELVPositive Net Change
medical medical-devices
Implied Volatility Surging for Prestige Consumer Stock Options
by Zacks Equity Research
Investors need to pay close attention to PBH stock based on the movements in the options market lately.
PBHNegative Net Change
medical medical-devices
SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits
by Zacks Equity Research
Sight Sciences highlights a new meta-analysis showing OMNI delivers lasting safety, efficacy and economic value in glaucoma treatment.
WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change SGHTPositive Net Change
medical medical-devices
Top Analyst Reports for AbbVie, ServiceNow & Boeing
by Mark Vickery
AbbVie, ServiceNow, and Boeing outpace their industries as analysts highlight growth drivers and risks in fresh research reports.
BANegative Net Change AMXPositive Net Change UBSPositive Net Change TCXPositive Net Change IDXXNegative Net Change APNegative Net Change ABBVPositive Net Change NOWPositive Net Change
aerospace computers internet-content medical-devices pharmaceuticals
Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
by Zacks Equity Research
ARAY sees strong order momentum, APAC growth and CyberKnife demand, but soft product sales and regional headwinds cloud near-term gains.
ARAYNegative Net Change WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change
medical medical-devices
SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care
by Zacks Equity Research
Stryker teams with Siemens Healthineers to develop a robotic ecosystem aimed at advancing stroke and aneurysm care.
SYKPositive Net Change WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change
medical medical-devices
Is it the Right Time to Retain Abbott Stock in Your Portfolio?
by Zacks Equity Research
ABT's strong Nutrition, Diabetes Care and EPD growth fuel momentum, but macro and currency headwinds challenge its outlook.
ABTPositive Net Change CAHPositive Net Change MASINegative Net Change PAHCPositive Net Change
medical medical-devices
Hologic's Strong International Traction to Continue Despite Headwinds
by Moumi Mondal
HOLX's global push shows strength, with surgical growth and rising diagnostics use offsetting near-term challenges.
ABTPositive Net Change TMOPositive Net Change HOLXNegative Net Change
medical medical-devices
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
by Zacks Equity Research
BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.
BAXPositive Net Change RMDPositive Net Change MASINegative Net Change SOLVPositive Net Change
medical medical-devices
Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio
by Zacks Equity Research
AVNS acquires Nexus Medical, adding its TKO connector to expand critical care offerings and drive immediate revenue and earnings growth.
BSXPositive Net Change WSTNegative Net Change MEDPNegative Net Change AVNSPositive Net Change
medical medical-devices